Medicine & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Lifeline Therapeutics, Inc.
Dr. Sally K. Nelson, Lifeline Therapeutics, Inc. science coordinator, presents antioxidant research
June 2nd, 2006
Lifeline Therapeutics, Inc. (LFLT), maker of Protandim, a patent-pending dietary supplement that increases the body's natural antioxidant defenses, announced Dr. Sally K. Nelson presented relevant research in a poster session at the SupplySide East International Trade Show and Conference in early May. Nelson's presentation focused on Protandim as a fundamentally new approach to antioxidant therapy. A recent human study - conducted by the University of Colorado at Denver and Health Sciences Center - found that Protandim increases the levels of the antioxidants superoxide dismutase (SOD) and catalase (CAT). The human body depends on its own catalytic antioxidant enzymes...
Source: Medicine & Law Weekly (2006-06-02)
|
